Author: AnneW

23andMe Provides An Update Regarding FDA’s Review

By Anne Wojcicki After discussion with officials from the Food and Drug Administration today, 23andMe will comply with the FDA’s directive and stop offering new consumers access to health-related genetic tests while the company moves forward with the agency’s regulatory review processes. 23andMe has ...

Read more

An Update Regarding The FDA’s Letter to 23andMe

23andMe was started in 2007 with the belief that consumers have the right to get access to their genetic information and that information can help them live healthier lives. It is absolutely critical that our consumers get high quality genetic data that they can trust.   We have worked extensively with our ...

Read more

One Million Strong, A Note from 23andMe’s Anne Wojcicki

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

Announcing 23andMe’s First Patent

[Ed: A clarifying addendum has been added to the end of this post. - 6/01/12] 23andMe has a substantial research arm with more than 20 scientists dedicated to making meaningful discoveries that will improve the lives of all of us.  We’ve made a number of discoveries that we’ve published in peer reviewed ...

Read more

Genetics and the Risks from Traumatic Brain Injuries

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Breast Cancer Research Goes Online

Clinical trials are often conducted at major hospitals and medical centers.  As you can imagine, it can be expensive to use hospital resources and take a large amount of doctors’ and nurses’ time. It can also be difficult to find people to participate in clinical trials.  For those who do participate, it ...

Read more

Before You Are Pregnant…

My sister learned she was a carrier for a recessive disease, Bloom syndrome, late in one of her pregnancies. I remember the panicked call and the weeks of worry as she and her husband awaited his test results; if he was also a carrier, this meant their daughter had a one in four chance of being born with the ...

Read more

Research participants have a right to their own genetic data

The Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH) is an exceptional study that has the potential to transform medicine.  As someone who proudly spent over 25 years as a patient with Kaiser, I would be excited to see my family's medical records used for such a worthy cause.  I was ...

Read more

23andMe Democratizes Personal Genomics With New Analytical Platform

By 23andMe Co-founders Linda Avey and Anne Wojcicki 23andMe is proud to announce a major step toward our goal of democratizing genetic information by giving our customers access to even more of their SNP data through our next generation custom content, all at a lower price. With the introduction of v2, ...

Read more

New Ideas: Personalized Medicine in the Developing World

Muhammad Yunus at his alma mater in Chittagong, Bangladesh 23andMe presented yesterday at the 11th Milken Institute Global Conference, taking place through Wednesday in Los Angeles. The conference has a significant health care focus, with session topics ranging from "Is the Pharmaceutical Well Drying out?" ...

Read more

Return to top